BamSEC and AlphaSense Join Forces
Learn More

Change Healthcare Inc

Formerly NASDAQ: CHNG
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.11
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Change Healthcare Inc. Common Stock
12/34/56
EX-4.1
from 8-K 17 pages Second Supplemental Indenture
12/34/56
EX-4.8
from S-4 41 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee First Supplemental Indenture Dated as of July 1, 2019 to Indenture Dated as of July 1, 2019 5.50% Senior Amortizing Notes Due 2022
12/34/56
EX-4.7
from S-4 51 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee Indenture Dated as of July 1, 2019 Senior Securities
12/34/56
EX-4.4
from S-4 120 pages Purchase Contract Agreement Dated as of July 1, 2019 Between Change Healthcare Inc. and U.S. Bank N.A., as Purchase Contract Agent, as Attorney-In-Fact for the Holders of Equity-Linked Securities From Time to Time as Provided Herein and as Trustee Under the Indenture Referred to Herein
12/34/56
EX-4.2
from S-4 5 pages Completion Date Supplemental Indenture
12/34/56
EX-4.1
from S-4 210 pages Indenture Dated as of February 15, 2017 Among Change Healthcare Holdings, LLC, as the Issuer, Change Healthcare Finance, Inc., as the Co-Issuer, and Wilmington Trust, National Association, as Trustee, Transfer Agent, Registrar and Paying Agent $1,000,000,000 5.75% Senior Notes Due 2025
12/34/56
EX-4.8
from DRS 41 pages The Registrant Has Requested Confidential Treatment of This Draft Registration Statement and Associated Correspondence Pursuant to Rule 83 of the Securities and Exchange Commission
12/34/56
EX-4.7
from DRS 51 pages The Registrant Has Requested Confidential Treatment of This Draft Registration Statement and Associated Correspondence Pursuant to Rule 83 of the Securities and Exchange Commission
12/34/56
EX-4.4
from DRS 120 pages The Registrant Has Requested Confidential Treatment of This Draft Registration Statement and Associated Correspondence Pursuant to Rule 83 of the Securities and Exchange Commission
12/34/56
EX-4.2
from DRS 5 pages The Registrant Has Requested Confidential Treatment of This Draft Registration Statement and Associated Correspondence Pursuant to Rule 83 of the Securities and Exchange Commission
12/34/56
EX-4.1
from DRS 210 pages The Registrant Has Requested Confidential Treatment of This Draft Registration Statement and Associated Correspondence Pursuant to Rule 83 of the Securities and Exchange Commission
12/34/56
EX-4.5
from 8-K 41 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee First Supplemental Indenture Dated as of July 1, 2019 to Indenture Dated as of July 1, 2019 5.50% Senior Amortizing Notes Due 2022
12/34/56
EX-4.4
from 8-K 51 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee Indenture Dated as of July 1, 2019 Senior Securities
12/34/56
EX-4.1
from 8-K 120 pages Purchase Contract Agreement Dated as of July 1, 2019 Between Change Healthcare Inc. and U.S. Bank N.A., as Purchase Contract Agent, as Attorney-In-Fact for the Holders of Equity-Linked Securities From Time to Time as Provided Herein and as Trustee Under the Indenture Referred to Herein
12/34/56
EX-4.4
from S-1/A 119 pages Purchase Contract Agreement Dated as of [•], 2019 Between Change Healthcare Inc. and U.S. Bank N.A., as Purchase Contract Agent, as Attorney-In-Fact for the Holders of Equity-Linked Securities From Time to Time as Provided Herein and as Trustee Under the Indenture Referred to Herein
12/34/56
EX-4.8
from S-1/A 40 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee First Supplemental Indenture Dated as of [●], 2019 to Indenture Dated as of [●], 2019 [•]% Senior Amortizing Notes Due 2022
12/34/56
EX-4.7
from S-1/A 51 pages Change Healthcare Inc., as Issuer, and U.S. Bank N.A., as Trustee Indenture Dated as of [•], 2019 Senior Securities
12/34/56
EX-4.4
from S-1/A 119 pages Purchase Contract Agreement Dated as of [•], 2019 Between Change Healthcare Inc. and U.S. Bank N.A., as Purchase Contract Agent, as Attorney-In-Fact for the Holders of Equity-Linked Securities From Time to Time as Provided Herein and as Trustee Under the Indenture Referred to Herein
12/34/56
EX-4.2
from S-1 5 pages Completion Date Supplemental Indenture
12/34/56